Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Altaire Pharmaceuticals, Inc. Issues Voluntary Recall Of Multiple Ophthalmic Products Sold By OCuSOFT


      News provided by

      Altaire Pharmaceuticals, Inc.

      Jul 15, 2019, 21:53 ET

      Share this article

      Share this article


      AQUEBOGUE, N.Y., July 15, 2019 /PRNewswire/ -- Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling the Prescription (RX) and Over-the-Counter (OTC) drug products and lots, within expiry, sold by OCuSOFT during the time period as indicated in the tables below. As a precautionary measure, Altaire is voluntarily initiating the recall due to management concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility. The FDA has determined these issues indicate a lack of sterility assurance. Administration of a non-sterile product intended to be sterile may result in serious and potentially life threatening infections or death. 

      This recall is being carried out to the RETAIL LEVEL and IS ONLY FOR THE SPECIFIC LOTS LISTED BELOW. No other lots are being recalled. A Retail Level recall is limited to product lots currently in inventory.

      Altaire further advises as follows:
      TO DATE ALTAIRE HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS FOR THE PRODUCTS.
      TO DATE ALTAIRE HAS NOT OBTAINED ANY OUT OF SPECIFICATIONS RESULTS, INCLUDING IN-HOUSE AND THIRD PARTY STERILITY TESTING, FOR THE PRODUCTS.

      Product Description: OCuSOFT Homatropine Hydrobromide Ophthalmic Solution 5%
      NDC #: 54799-431-05   Product Size: 5 mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17186

      6/20

      9/19/2017

      17345

      11/20

      1/12/2018

      19010

      1/22

      3/01/2019

      Product Description: OCuSOFT Tetcaine Hydrochloride Ophthalmic Solution USP, 0. 5%
      NDC #: 54799-502-15   Product Size: 15 mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17205

      7/19

      9/19/2017

      17206

      7/19

      9/19/2017

      18003

      1/20

      2/21/2018

      18097

      4/20

      5/25/2018

      18166

      7/20

      9/10/2018

      18292

      11/20

      12/19/2018

      19106

      4/21

      6/13/2019

      Product Description: OCuSOFT Goniosoft Hypromellose 2.5% Ophthalmic Demulcent Solution
      NDC #: 54799-503-15   Product Size: 15 mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17303

      10/20

      12/21/2017

      18032

      2/21

      2/21/2018

      18235

      9/21

      10/29/2018

      18285

      11/21

      12/19/2018

      19021

      1/22

      3/01/2019

      Product Description: OCuSOFT Tetravisc Forte
      NDC #: 54799-504-01   Product Size: 0.6 mL x 12 pcs

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17217

      7/19

      11/10/2017

      18256

      10/20

      11/27/2018

      Product Description: OCuSOFT Tetravisc Forte
      NDC #: 54799-504-05   Product Size: 5 mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17198

      7/19

      10/24/2017

      17199

      7/19

      10/24/2017

      17233

      8/19

      10/24/2017

      17337

      11/19

      12/21/2017

      17338

      11/19

      12/21/2017

      18248

      10/20

      11/27/2018

      Product Description: OCuSOFT Tetravisc
      NDC #: 54799-505-01   Product Size: 0.6 mL x 12 pcs

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17236

      8/19

      11/10/2017

      17334

      11/19

      12/21/2017

      18015

      1/20

      3/16/2018

      Product Description: OCuSOFT Tetravisc
      NDC #: 54799-505-05   Product Size: 5 mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17232

      8/19

      10/24/2017

      17334

      11/19

      12/21/2017

      18249

      10/20

      11/27/2018

      19125

      4/21

      6/13/2019

      Product Description: OCuSOFT Flucaine
      NDC #: 54799-507-21   Product Size: 5 mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17255

      8/20

      9/19/2017

      17362

      12/20

      12/21/2017

      18089

      4/21

      5/28/2018

      18138

      6/21

      6/22/2018

      18146

      6/21

      6/28/2018

      18210

      8/21

      9/10/2018

      18211

      8/21

      9/10/2018

      18272

      11/21

      11/27/2018

      18273

      11/21

      12/19/2018

      18276

      11/21

      12/19/2018

      Product Description: OCuSOFT Eye Wash
      NDC #: 54799-565-01   Product Size: 1fl oz

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      18026

      1/21

      2/21/2018

      18100

      4/21

      9/10/2018

      19052

      2/22

      4/10/2019

      19130

      5/22

      6/13/2019

      Product Description: OCuSOFT Eye Wash
      NDC #: 54799-565-59   Product Size: 4 fl oz

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      16268

      10/19

      11/07/2016

      16301

      11/19

      12/09/2016

      17088

      3/20

      4/28/2017

      17109

      4/20

      6/14/2017

      17318

      10/20

      11/10/2017

      17323

      10/20

      1/12/2018

      18014

      1/21

      2/21/2018

      18045

      2/21

      3/16/2018

      18059

      3/21

      5/25/2018

      18063

      3/21

      4/2/2018

      18117

      5/21

      6/22/2018

      18134

      5/21

      7/26/2018





      Product Description: OCuSOFT Tears Again Lubricant Eye Drops
      NDC #: 54799-904-15   Product Size: 15 mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17209

      7/21

      9/19/2017

      18168

      7/22

      7/26/2018

      18217

      8/22

      10/29/2018

      18260

      10/22

      11/27/2018

      19094

      4/23

      6/13/2019

      Product Description: OCuSOFT Tears Again Lubricant Eye Drops
      NDC #: 54799-904-30   Product Size: 30mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      17208

      7/21

      11/10/2017

      17209

      7/21

      11/10/2017

      19001

      1/23

      4/10/2019

      Product Description: OCuSOFT Tears Again Lubricant Eye Ointment Nighttime Relief
      NDC #: 54799-906-35   Product Size: 3.5g

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      RHE

      8/20

      8/18/2017

      SCD

      3/21

      4/02/2018

      Product Description: OCuSOFT retaine NaCl Ophthalmic Ointment
      SKU #: 777-3-76   Product Size: 3.5g

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      SAP

      1/20

      3/16/2018

      SFI

      6/20

      10/29/2018

      TCI

      3/21

      6/13/2019

      Product Description: OCuSOFT retaine NaCl Ophthalmic Solution
      SKU #: 777-3-77    Product Size: 15mL

      Lot Number

      Expiration Date

      Manufacturer Initial Ship Date

      18008

      1/20

      6/22/2018

      19105

      4/22

      6/13/2019

      The above products are labeled exclusively for OCuSOFT. Altaire ships the products labeled for OCuSOFT only to OCuSOFT. The products are distributed at the retail level by OCuSOFT. Altaire has also requested that OCuSOFT perform a subrecall.

      Altaire has notified OCuSOFT by e-mail on July 15, 2019 announcing the recalls of the products/lots identified herein, with specific directions for return of all units of the impacted lots.

      Any questions regarding this VOLUNTARY RECALL to the RETAIL LEVEL can be directed to Altaire Pharmaceuticals Inc., by calling 1-800-258-2471, or e-mailing [email protected] Monday thru Friday from 8:30 a.m. to 5:00 p.m. ET.

      Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

      Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

      • Online:www.fda.gov/medwatch/report.htm
      • Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
      • Fax: 1-800-FDA-0178

      This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

      Altaire takes its mission of customer safety and providing quality products very seriously. The company is committed to, and diligently working to, ensure the sufficiency of Quality Assurance controls over critical systems in its manufacturing facility.

      Company Contacts:
      Michael Sawaya
      Joseph Sawaya
      1-800-258-2471

      SOURCE Altaire Pharmaceuticals, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.